DE3774501D1 - Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel. - Google Patents

Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel.

Info

Publication number
DE3774501D1
DE3774501D1 DE8787109415T DE3774501T DE3774501D1 DE 3774501 D1 DE3774501 D1 DE 3774501D1 DE 8787109415 T DE8787109415 T DE 8787109415T DE 3774501 T DE3774501 T DE 3774501T DE 3774501 D1 DE3774501 D1 DE 3774501D1
Authority
DE
Germany
Prior art keywords
gangliosides
tumm
exogenic
production
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787109415T
Other languages
English (en)
Inventor
Valle Francesco Della
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of DE3774501D1 publication Critical patent/DE3774501D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787109415T 1986-06-30 1987-06-30 Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel. Expired - Lifetime DE3774501D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8648203A IT1208751B (it) 1986-06-30 1986-06-30 Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali

Publications (1)

Publication Number Publication Date
DE3774501D1 true DE3774501D1 (de) 1991-12-19

Family

ID=11265194

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19873721562 Withdrawn DE3721562A1 (de) 1986-06-30 1987-06-30 Verwendung exogener ganglioside als schutzfaktor bei tumorerkrankungen
DE8787109415T Expired - Lifetime DE3774501D1 (de) 1986-06-30 1987-06-30 Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19873721562 Withdrawn DE3721562A1 (de) 1986-06-30 1987-06-30 Verwendung exogener ganglioside als schutzfaktor bei tumorerkrankungen

Country Status (16)

Country Link
US (1) US5229373A (de)
EP (1) EP0251298B1 (de)
JP (1) JPS6327434A (de)
AT (1) ATE69381T1 (de)
AU (1) AU601988B2 (de)
BE (1) BE1000723A4 (de)
CA (1) CA1314219C (de)
DE (2) DE3721562A1 (de)
DK (1) DK165621C (de)
ES (1) ES2038621T3 (de)
FR (1) FR2601248B1 (de)
GR (2) GR871005B (de)
IL (1) IL82944A (de)
IT (1) IT1208751B (de)
LU (1) LU86930A1 (de)
ZA (1) ZA874597B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254280B (it) * 1992-03-13 1995-09-14 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
US6765087B1 (en) * 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
DE4430041A1 (de) † 1994-08-24 1996-02-29 Milupa Ag Allergieprotektive Formelnahrung
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
EP1603932B1 (de) 2003-03-06 2012-10-03 Seneb Biosciences Inc. Verfahren und zusammensetzungen für die enzymatische synthese von gangliosiden
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali

Also Published As

Publication number Publication date
JPS6327434A (ja) 1988-02-05
DK333787D0 (da) 1987-06-29
IT1208751B (it) 1989-07-10
GR3003790T3 (de) 1993-03-16
LU86930A1 (fr) 1987-11-11
DK333787A (da) 1987-12-31
BE1000723A4 (fr) 1989-03-21
IL82944A (en) 1993-04-04
FR2601248A1 (fr) 1988-01-15
GR871005B (en) 1987-10-23
EP0251298A3 (en) 1988-10-26
EP0251298A2 (de) 1988-01-07
AU7490887A (en) 1988-01-07
AU601988B2 (en) 1990-09-27
FR2601248B1 (fr) 1989-08-25
DK165621C (da) 1993-06-01
ATE69381T1 (de) 1991-11-15
DE3721562A1 (de) 1988-03-03
DK165621B (da) 1992-12-28
EP0251298B1 (de) 1991-11-13
ZA874597B (en) 1988-03-30
ES2038621T3 (es) 1993-08-01
CA1314219C (en) 1993-03-09
US5229373A (en) 1993-07-20
IT8648203A0 (it) 1986-06-30

Similar Documents

Publication Publication Date Title
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
EP0403048A3 (de) Medizinische Sucralfat enthaltende Zusammensetzungen und Verfahren zur Herstellung
DE3774501D1 (de) Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
CA2163197A1 (en) Tri(platinum) complexes
DE3675977D1 (de) Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebs-chemotherapie und erhoehung der immunitaet.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
ITMI920591A1 (it) Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
AU9045491A (en) Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same
FR2381786A1 (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments
DE3363975D1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
ATE45953T1 (de) Anthracyclinderivate, deren verfahren zur herstellung und deren pharmazeutische zusammensetzung und deren benuetzung als arznei.
DE69330269D1 (de) Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel
IT1236584B (it) Uso di gangliosidi nel trattamento della disfunzione autonomica nel morbo di chagas
IT1251992B (it) Composizioni farmaceutiche ad uso orale,a base di esteri interni di gangliosidi, per il trattamento di patologie del sistema nervoso centrale
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2376151A1 (fr) Derives de pyrimidoquinoxaline, procede pour leur preparation et medicament contre l'asthme allergique contenant ces derives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee